Retrospective comparative survival analysis of ablation plus systemic therapy versus systemic therapy alone for breast cancer liver metastases, stratified by extrahepatic metastases status
Background: Current decision-making for the treatment of breast cancer liver metastases (BCLM) using ablation lacks strong evidence, especially for patients combined with extrahepatic metastases. Purpose: To assess whether ablation plus systemic therapy (AS) improves survival outcomes in patients wi...
Saved in:
Main Authors: | Xuxiazi Zou, Hong-Liang Zou, Xuan Luo, Xu-Wei Chen, Wei-Ling Huang, Chao Zhang, Ge Ren, Jin-Hua Huang, Xue Han, Yi-Quan Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Breast |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977625000050 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modern treatment methods of patients with liver metastases of colorectal cancer
by: Ye. N. Grebenkin, et al.
Published: (2013-07-01) -
Local control and recurrence patterns after stereotactic irradiation delivered in more than 4 fractions for hepatocellular carcinomas and liver metastases: a retrospective study
by: Alizée Renan, et al.
Published: (2025-02-01) -
Successful Combined Treatment of a Patient with Borderline Resectable Liver Metastasis of Colorectal Cancer
by: O. Yu. Stukalova, et al.
Published: (2023-05-01) -
Evolving prognostic paradigms in lung adenocarcinoma with brain metastases: a web-based predictive model enhanced by machine learning
by: Min Liang, et al.
Published: (2025-02-01) -
Thromboelastography parameters in chronic viral liver disease and liver resection: a retrospective study
by: Ying Di, et al.
Published: (2024-08-01)